Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Cloning, characterization and clinical evaluation of Aspergillus fumigatus allergens
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.01.1995 31.12.1997 Project funding (Div. I-III)

Molecular interactions regulating innate, adaptive and regulatory responses in allergic diseases
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.04.2010 31.03.2011 R'EQUIP

Cloning, molecular and structural characterisation of fungal allergens and of functionally related cross-reactive human auto- antigens
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.01.1998 30.04.2001 Project funding (Div. I-III)

Rapid cloning of allergen repertoires by phage surface display ofcDNA libraries and high density arrays
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.05.2001 30.09.2006 Project funding (Div. I-III)

NANOASIT - Novel drug delivery routes mediated via nanotechnology; targeting allergy vaccination (ERA-Net EuroNanoMed)
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.08.2011 31.07.2014 ERA-Euro-NanoMed

Cloning and characterization of antigens inducing human poly- clonal IgE response in Aspergillus fumigatus associated allergic pulmonary diseases
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.06.1991 31.05.1994 Project funding (Div. I-III)

Improving diagnosis and treatment of allergic diseases by avandgarde technologies
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.03.2014 31.12.2017 Project funding (Div. I-III)

Characterization of modular antigen transporter vaccines targeting the MHC class II antigen presentation pathway
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.10.2006 30.09.2009 Project funding (Div. I-III)

Route of application and mode of action of modular antigen transporter (MAT) allergy vaccines
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.10.2009 30.09.2012 Project funding (Div. I-III)

Allergy vaccination using novel drug delivery routes mediated via nanotechnology (ERANet EuroNanoMed2 NANOASITII)
Crameri Reto Swiss Institute of Allergy and Asthma Research - SIAF 01.03.2014 31.12.2017 ERA-Euro-NanoMed

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

The role of IgE-mediated autoimmunity in the pathogenesis of atopic dermatitis
Schmid-Grendelmeier Peter University of Zurich - ZH 01.04.2005 30.04.2005 Project funding (Div. I-III)

Targeted elimination of IgE memory B cells and serum IgE through active vaccination
Rhyner Claudio Swiss Institute of Allergy and Asthma Research - SIAF 01.01.2012 31.12.2014 Project funding (Div. I-III)

Clinical development of a novel approach to allergen specific immunotherapy using transcutaneous vaccination
Senti Gabriela University of Zurich - ZH 01.05.2009 30.09.2011 Project funding (Div. I-III)

Analysis of regulatory mechanisms in allergy with high-throughput and novel technologies
Akdis Cezmi Swiss Institute of Allergy and Asthma Research - SIAF 01.07.2006 30.06.2007 R'EQUIP

-